Pulmonary Hypertension of Newborn
6
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
1 terminated out of 6 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH
Measuring Heart Health in Both Term, Preterm and Unwell Newborn Babies With an Advanced Ultrasound Method: Speckle Tracking Echocardiography
A Real-world Study of Nitric Oxide Generator and Delivery System
Identification of the Risk of Remote Pulmonary Hypertension in Preterm Births.
Echocardiographic Screening of Healthy Neonates for Measuring Pulmonary Artery Pressure
Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension